Profile Dr Paul Gregorevic
Dr. Gregorevic gained his Ph.D. in Physiology from The University of Melbourne in 2001 and completed postdoctoral training at The University of Melbourne, and The University of Washington, USA before attaining a faculty appointment in the Department of Neurology at The University of Washington in 2007.
In 2008, Dr. Gregorevic relocated his research program to the Baker IDI Heart & Diabetes Institute, Melbourne, where he is Head of the Laboratory for Muscle Research and Therapeutics Development, and Director of the Recombinant Viral Vector Core. Dr. Gregorevic has authored numerous papers, reviews and book chapters concerning the mechanisms of skeletal muscle function and adaptation, neuromuscular disorders, and intervention strategies for their treatment.
Recent awards include the 2006 A.K. McIntyre Medal from the Australian Physiological Society, for outstanding achievements in the physiological sciences, and the 2007 Pfizer Australia Senior Research Fellowship for outstanding young scientists.
Publications
- rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med.12:787. Gregorevic P, et al. 2006.
- Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther. 10:671. Blankinship MJ, et al. 2004.
- Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med. 10:828. Gregorevic P, et al 2004.
